MA29000B1 - Composes d'acide 4-methoxymethyl-pyrrolidine-2-carboxylique et leurs derives utilises comme inhibiteurs du virus de l'hepatite c - Google Patents

Composes d'acide 4-methoxymethyl-pyrrolidine-2-carboxylique et leurs derives utilises comme inhibiteurs du virus de l'hepatite c

Info

Publication number
MA29000B1
MA29000B1 MA29846A MA29846A MA29000B1 MA 29000 B1 MA29000 B1 MA 29000B1 MA 29846 A MA29846 A MA 29846A MA 29846 A MA29846 A MA 29846A MA 29000 B1 MA29000 B1 MA 29000B1
Authority
MA
Morocco
Prior art keywords
methoxymethyl
pyrrolidine
hepatitis
virus
inhibitors
Prior art date
Application number
MA29846A
Other languages
English (en)
Inventor
Rossella Guidetti
David Haigh
Charles David Hartley
Peter David Howes
Fabrizio Nerozzi
Stephen Allan Smith
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33485164&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA29000(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MA29000B1 publication Critical patent/MA29000B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MA29846A 2004-10-25 2007-04-25 Composes d'acide 4-methoxymethyl-pyrrolidine-2-carboxylique et leurs derives utilises comme inhibiteurs du virus de l'hepatite c MA29000B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0423673.3A GB0423673D0 (en) 2004-10-25 2004-10-25 Compounds

Publications (1)

Publication Number Publication Date
MA29000B1 true MA29000B1 (fr) 2007-11-01

Family

ID=33485164

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29846A MA29000B1 (fr) 2004-10-25 2007-04-25 Composes d'acide 4-methoxymethyl-pyrrolidine-2-carboxylique et leurs derives utilises comme inhibiteurs du virus de l'hepatite c

Country Status (18)

Country Link
US (1) US20070270475A1 (fr)
EP (1) EP1805172A1 (fr)
JP (1) JP2008517968A (fr)
KR (1) KR20070072614A (fr)
CN (1) CN101087785A (fr)
AR (1) AR051340A1 (fr)
AU (1) AU2005298849A1 (fr)
BR (1) BRPI0517023A (fr)
CA (1) CA2585170A1 (fr)
GB (1) GB0423673D0 (fr)
IL (1) IL182583A0 (fr)
MA (1) MA29000B1 (fr)
MX (1) MX2007004914A (fr)
NO (1) NO20072547L (fr)
PE (1) PE20060602A1 (fr)
RU (1) RU2007119390A (fr)
TW (1) TW200630365A (fr)
WO (1) WO2006045613A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
EP2142215B1 (fr) 2007-05-04 2012-03-07 Vertex Pharmceuticals Incorporated Thérapie combinée pour le traitement d'une infection par le vhc
UA103195C2 (uk) 2008-08-11 2013-09-25 Глаксосмитклайн Ллк Похідні пурину для застосування у лікуванні алергій, запальних та інфекційних захворювань
BRPI0917458A2 (pt) 2008-08-11 2015-12-01 Glaxosmithkline Llc composto, método de tratamento de doenças e condições, composição farmacêutica, método para tratar ou prevenir doença, e, uso de um composto
BRPI0917013A2 (pt) 2008-08-11 2016-02-16 Glaxosmithkline Llc métodos para tratar doenças alérgicas e outras condições inflamatórias, e para tratar ou prevenir doença, composto, composição farmacêutica, e, uso de um composto
WO2011098451A1 (fr) 2010-02-10 2011-08-18 Glaxosmithkline Llc Dérivés de purine et leurs utilisations pharmaceutiques
DK2534149T3 (da) 2010-02-10 2015-01-05 Glaxosmithkline Llc 6-amino-2-{ [ (1s)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8h-purin-8-on-maleat
KR20160124157A (ko) 2014-02-20 2016-10-26 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 인간 인터페론의 유도인자로서의 피롤로[3,2]피리미딘 유도체
IL247927B (en) 2014-05-07 2022-09-01 Boehringer Ingelheim Int Container, a device that turns a liquid into a fine spray and use
MX2017006302A (es) 2014-11-13 2018-02-16 Glaxosmithkline Biologicals Sa Derivados de adenina que son utiles en el tratamiento de enfermedades alergicas u otras afecciones inflamatorias.
CN107849084B (zh) 2015-12-03 2021-09-14 葛兰素史密斯克莱知识产权发展有限公司 作为sting调节剂的环状嘌呤二核苷酸
JP2019510802A (ja) 2016-04-07 2019-04-18 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ タンパク質調節物質として有用な複素環アミド
PT3440076T (pt) 2016-04-07 2022-07-29 Glaxosmithkline Ip Dev Ltd Amidas heterocíclicas úteis como modeladores de proteína
CA3077337A1 (fr) 2017-10-05 2019-04-11 Glaxosmithkline Intellectual Property Development Limited Modulateurs de stimulateur des genes (sting) de l'interferon
AU2018344902B2 (en) 2017-10-05 2021-06-03 Glaxosmithkline Intellectual Property Development Limited Modulators of stimulator of interferon genes (STING) useful in treating HIV
GB201807924D0 (en) 2018-05-16 2018-06-27 Ctxt Pty Ltd Compounds
US20220227761A1 (en) 2019-05-16 2022-07-21 Stingthera, Inc. Oxoacridinyl acetic acid derivatives and methods of use
WO2020232378A1 (fr) 2019-05-16 2020-11-19 Silicon Swat, Inc. Dérivés d'acide acétique benzo[b][1,8]naphtyridine et leur procédés d'utilisation
GB201910304D0 (en) 2019-07-18 2019-09-04 Ctxt Pty Ltd Compounds
GB201910305D0 (en) 2019-07-18 2019-09-04 Ctxt Pty Ltd Compounds
EP4077318B1 (fr) 2019-12-18 2025-10-15 Ctxt Pty Ltd Dimères de benzimidazole en tant que modulateurs de sting
US12274700B1 (en) 2020-10-30 2025-04-15 Accencio LLC Methods of treating symptoms of coronavirus infection with RNA polymerase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60325498D1 (de) * 2002-10-24 2009-02-05 Glaxo Group Ltd 1-acyl-pyrrolidin-derivate für die behandlung von viralen infektionen

Also Published As

Publication number Publication date
RU2007119390A (ru) 2008-12-10
BRPI0517023A (pt) 2008-09-30
AR051340A1 (es) 2007-01-03
CA2585170A1 (fr) 2006-05-04
JP2008517968A (ja) 2008-05-29
GB0423673D0 (en) 2004-11-24
WO2006045613A1 (fr) 2006-05-04
EP1805172A1 (fr) 2007-07-11
US20070270475A1 (en) 2007-11-22
IL182583A0 (en) 2007-07-24
PE20060602A1 (es) 2006-07-15
AU2005298849A1 (en) 2006-05-04
NO20072547L (no) 2007-07-23
TW200630365A (en) 2006-09-01
CN101087785A (zh) 2007-12-12
MX2007004914A (es) 2007-06-12
KR20070072614A (ko) 2007-07-04

Similar Documents

Publication Publication Date Title
MA29000B1 (fr) Composes d'acide 4-methoxymethyl-pyrrolidine-2-carboxylique et leurs derives utilises comme inhibiteurs du virus de l'hepatite c
EP1660099A4 (fr) Distribution intravasculaire d'acide nucleique non viral
EP2097111A4 (fr) Hétérodimères d'acide glutamique
EP2178897A4 (fr) Séquences d'acide nucléique pour l'amplification et la détection de virus respiratoires
DE60119283D1 (de) Verfahren zur herstellung von 3-hydroxypicolinsäure-derivaten
EP1763531A4 (fr) Analogues peptidiques d'inhibiteurs de l'hepatite c
EP1753708A4 (fr) Noveaux composes activant sirtuine et leurs methodes de preparation
MA28365A1 (fr) Derives d'aryl-et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application comme inhibiteurs de l'enzyme faah
DE602004024402D1 (de) Verfahren zur herstellung von tetrazolderivaten au
EP1673384A4 (fr) Composes d'acide glutamique nitroses, leurs compositions et procedes d'utilisation
NO20032822D0 (no) Fremgangsmåte for konsentrering av brukt syre
IS8231A (is) Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða
ATE504580T1 (de) Malonsäureamidderivate als inhibitoren von g- sekretase zur behandlung von alzheimer-krankheit
MA28804B1 (fr) Formulations d'acide suberoylanilide hydroxamique et leurs procedes de production
DE50205766D1 (de) Verfahren zur herstellung von 2-halogenpyridincarbonsäureamiden
EP1591524A4 (fr) Oligoribonucleotide ou acide nucleique peptidique inhibant la fonction du virus de l'hepatite c
EP1771585A4 (fr) Compositions et procedes de detection d'un acide nucleique du virus de l'hepatite a
FR2878850B1 (fr) Derives de l'inositol-1-phosphate
NO20084860L (no) Stabile farmasøytiske preparater av 2-aza-bisyklo-[3,3,0]-oktan-3-karboksylsyrederivater
IS8232A (is) Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða
EP1874755A4 (fr) Derives benzothiophene d'acide hydroxamique
DE502005009157D1 (de) Verfahren zur herstellung von alkenylbernsteinsäureanhydriden
EP1776100A4 (fr) Traitement du cancer au moyen de derives d'acide benzoique
EP1677599A4 (fr) Composes pyridopyrrolopyrazine dione hydroxy utiles comme inhibiteurs de l'integrase du vih
EP2090169A4 (fr) Agent dégradant l'acide nucléique et procédé de dégradation de l'acide nucléique